David Wainer is a columnist at The Wall Street Journal. He focuses on themes related to medicine and healthcare, alternative medicine, and health and wellness, while also exploring intersections with business and economics. His insights have been featured in prominent outlets such as The Wall Street Journal, Yahoo Finance, LiveMint, Yahoo News, and JD Supra.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
David Wainer's coverage predominantly focuses on investment analysis within the healthcare and pharmaceutical sectors. His articles encompass a range of topics, including stocks, biotech, and investing in relation to developments within these industries.
Given his focus on investment analysis and citation of data, David would likely be interested in receiving pitches from experts who can provide insightful perspectives backed by data related to healthcare and pharmaceutical companies' performance or industry trends. Additionally, professionals with expertise in financial analysis specific to the healthcare sector may find success when reaching out to him.
Considering his concentration on the international market rather than a specific geographic area, sources providing global insights into healthcare investments and pharmaceutical developments could capture his attention effectively.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: David Wainer
Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as Humana and CVS look better positioned.
Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as Humana and CVS look better positioned.
Growing public scrutiny and tighter regulation are testing a long successful vertical-integration strategy.
By: David Wainer
After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.
By: David Wainer
Investors long trusted UnitedHealth to deliver earnings beats, despite limited transparency. Now they want answers.
By: David Wainer
Investors long trusted UnitedHealth to deliver earnings beats, despite limited transparency. Now they want answers.
Israeli markets rose to record highs Wednesday, continuing to outperform U.S. benchmarks despite the ongoing conflict with Iran.
(833) 317-6278 
